Skip to content
May 14, 2018/

Exiger FCPA Expert to Speak at 12th International Pharmaceutical and Medical Device Compliance Congress

Managing Director ‘George “Ren” McEachern will share his anti-bribery and corruption expertise with senior compliance and legal officers from across the globe at the 12th International Pharmaceutical and Medical Device Congress in Vienna. Ren will join the Anti-Corruption Roundtable on Tuesday, May 15 at 11:30am, alongside representatives from Clifford Chance, Baker & McKenzie, Covington, McGuire Woods and Ernst & Young.The 2018 Congress is centered around relevant Global Pharma and Medical Device Compliance Codes Update, current compliance issues, and emerging trends pertaining to:Anti-corruption and Anti-bribery PolicyRelationships with Patient Support ProgramsDirect Sponsorship of Healthcare Professionals at Third Party EventsThird-Party Risk Management, Due Diligence, and Compliance MonitoringEU General Data Protection Regulation (GDPR)Social Responsibility and the Ethics of Artificial IntelligenceCompliance Issues in Market access and Outcomes-Based Value-Added Services, andThe next generation of ethics and compliance programs.For more information about the event, click here._____________________________________Learn more about Exiger’s Anti-Bribery and Corruption solutions.

trust
VIEW BIO

Sed ac libero nisi. Proin scelerisque sapien ligula, a varius libero posuere eget. Donec sit amet ipsum ornare, aliquet ex vel, sodales dui. Nam a justo ultricies, tincidunt enim at, egestas nulla. Praesent justo dolor, faucibus a scelerisque at, sagittis convallis est. Quisque posuere, orci quis vulputate ullamcorper, lectus sapien posuere nisl, suscipit gravida augue sapien id massa.

The risk landscape is constantly changing. Hear about the latest with Exiger.

White Paper

Preparing the U.S. Bulk Power Supply for the Next Generation of Threats

Article

Building Resilience in a Time of Unprecedented Change

White Paper

The Case for Regular Look Backs in the RCBI Compliance Framework